Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CART-19 T Cells in Pediatric B-Cell Malignancies
NCT01626495Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2011
- Primary completion
- May 2018
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of tisagenlecleucel in acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), mantle cell lymphoma (MCL), B-cell prolymphocytic leukemia (B-PLL), sponsored by University of Pennsylvania. Started Aug 2011; status: completed.
02
Drugs
tisagenlecleucel
03
Conditions
acute lymphoblastic leukemia (ALL)chronic lymphocytic leukemia (CLL)follicular lymphoma (FL)mantle cell lymphoma (MCL)B-cell prolymphocytic leukemia (B-PLL)
Beyond the preview
Go deeper on NCT01626495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01626495.